InsidersTradesSigma
Browse the full record of transactions filed by Walton Thomas Layton, Autre. Insider active across 1 companies, notably BiomX Inc.. In total, 1 reports have been recorded. The latest transaction was filed on 31 December 2021 — J. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Thomas Layton Walton is involved with BiomX Inc. Although his specific role is not detailed, he contributes to the strategic direction of the company. BiomX focuses on developing bacteriophage-based treatments for various diseases. Thomas Layton Walton brings his expertise to support innovation and research within the company.